Vietnam’s Vinmec Healthcare System received platinum awards for Best Community Program, Best Workplace Practices, Empowerment of Women, and Best Country Excellence in Vietnam in the US$1 billion and above market capitalization category.

Founded in 2012 to contribute to sustainable development in the Vietnamese healthcare sector by delivering high-quality medical services, Vinmec stands as a beacon of academic healthcare, dedicated to shaping the global healthcare narrative through innovative research, groundbreaking discoveries, and a steadfast commitment to clinical excellence and value-based care solutions.

In an interview with ACN Newswire, Vinmec CEO Le Thuy Anh discusses the company's visionary objectives and operational aspirations, and how, amid an era marked by pressing healthcare challenges, the company’s resilience, foresight, and unwavering dedication are helping transcend geographical boundaries by creating a sustainable healthcare ecosystem.

ACN: Can you share with us the vision and mission of Vinmec, particularly its dedication to academic healthcare for people at local and global scales?

Le Thuy Anh: Vinmec’s vision revolves around addressing critical healthcare challenges nationally and globally, especially in light of the transition from communicable to non-communicable diseases and an aging population. Vinmec is pioneering as an agent of change based on a model of academic medicine with three pillars: excellence in clinical programs; innovative research; and medical education. Aligning with this vision, Vinmec’s mission is caring with compassion, professionalism, and wisdom based on the core values of C.A.R.E (Creativity, Accountability, Reliability, Excellence). Based on this, we aim to contribute significantly to sustainable healthcare development by delivering high-quality medical services, focusing on academic healthcare through innovative research and clinical excellence.

ACN: How does Vinmec approach innovation, research, and breakthroughs to achieve clinical excellence?

Le Thuy Anh: Our approach to innovation and research is integral to achieving clinical excellence. We invest significantly in research and technology transfer, operate research institutes like Vinmec Research Institute of Stem Cells and Gene Technology (VRISG) for stem cell therapies, and the Hi-tech Center for groundbreaking trials.

VRISG is a pioneering research institute specializing in stem cell therapies for a range of rare diseases and is also the first to utilize CAR-T cell therapy for leukemia treatment in Vietnam. Vinmec's Hi-tech Center has achieved significant milestones, including conducting large-scale clinical trials for COVID-19 vaccines, successful international clinical trials on the efficacy of new cancer drugs, and becoming a reference laboratory for renowned medical partners like AstraZeneca.

Our emphasis on cutting-edgeinnovative applications like 3D printing and robotic surgery ensures clinical excellence and value-based solutions for our patients.

Click here to continue